Going by what was reported by Talon regarding the MTL test, Mayo ended enrollment in April. So, let's say they enrolled their last patient in April, they would complete the trial with this last patient following the time-frame below:
ARM I: Patients apply menadione topical lotion twice daily (BID) for 28 days.
ARM II: Patients apply topical placebo lotion BID for 28 days.
After completion of study treatment, patients are followed up for 4 weeks.
Therefore, wouldn't it seem logical that during July, the report is being completed?